A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma
Clinical trial NCT03810976 · COMPLETED
Trial details
- NCT number
- NCT03810976
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-27
- Primary completion
- 2022-05-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.